AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2014
Apr 18, 2014
32044_dirs_2014-04-18_fd071432-81fe-4da2-9ee6-7f88013f14ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2014-04-16
Reporting Person: Turley James S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-04-16 | Common Stock | A | 3058 | $19.62 | Acquired | 3058 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-04-16 | Option to Purchase Common Stock (Right to Buy) | $19.62 | A | 55000 | Acquired | 2024-04-16 | Common Stock (55000) | Direct |
Footnotes
F1: 15,000 options vested upon grant and are exercisable immediately. The remaining 40,000 options vest annually in increments of 10,000 on each of April 16, 2015, 2016, 2017 and 2018.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23